0
Medtech
  • Home
  • Insights
  • APAC ▾
    • Medical Device Manufacturing
    • MedTech
    • Orthopedic
  • Europe ▾
    • In Vitro Diagnostics
    • Medical Device Manufacturing
    • Medical Imaging
    • Medtech
    • Orthopedic
  • Conferences
  • Newsletter
  • Subscribe
  • News
  • Whitepaper
  • About Us
  • CardioVascular
  • Haematology
  • Neurology
  • Orthopedic
  • Drug Delivery Device
  • Manufacturing
  • MedTech
  • Oncology
  • Urology
  • Veterinary
  • Respiratory Devices
  • MedTech Devices Startups
  • Startups
  • Gynaecology
  • Nephrology
  • Medical Device
  • Physiotherapy
  • Dental
  • Surgical
  • Simulation
  • Pediatrics
  • Imaging
  • Chronic Care
  • Biomechanics
  • Nanomedicine
  • Dermatology
  • Endoscopy
  • Ophthalmics
  • Ultrasound
  • Robotics
  • Wound Care
  • Diabetes Care
  • Packaging and Sterilization
  • In Vitro Diagnostics
  • CardioVascular
  • Haematology
  • Neurology
  • Orthopedic
  • Drug Delivery Device
  • Manufacturing
  • MedTech
  • Oncology
  •   MORE
      • Urology
      • Veterinary
      • Respiratory Devices
      • MedTech Devices Startups
      • Startups
      • Gynaecology
      • Nephrology
      • Medical Device
      • Physiotherapy
      • Dental
      • Surgical
      • Simulation
      • Pediatrics
      • Imaging
      • Chronic Care
      • Biomechanics
      • Nanomedicine
      • Dermatology
      • Endoscopy
      • Ophthalmics
      • Ultrasound
      • Robotics
      • Wound Care
      • Diabetes Care
      • Packaging/Sterilization
      • In Vitro Diagnostics
×
#

Medical Tech Outlook Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook

Subscribe

loading

THANK YOU FOR SUBSCRIBING

Editor's Pick(1 - 4 of 8)
left
Consumerism is Igniting New Care Delivery Approaches

Kristin Darby, CIO, Cancer Treatment Centers of America

Finding New IT Solutions in an Increasingly Complex Healthcare Environment

Rich Temple, CIO & VP, Deborah Heart and Lung Center

The New Frontier for Healthcare Analytics

Benson Hsu, VP, Data and Analytics, Sanford Health

Impact on Diabetes and Hypertension Control Operational Schemes using Telemedicine Techniques

Anu Banerjee, Chief Quality and Innovation Officer, Arnot Health

You Can't Have One Without The Other: Value And Tech

Thomas J. Van Gilder, M.D., Chief Medical Officer, Transcend Insights

Transforming Cardio-Vascular Healthcare Systems

Vincent J Pompili MD. FACC, FSCAI, SVP, Novant Health

Diagnostic Devices Transforming The Cardiovascular Space

Mina Jacob, Interventional Cardiologist, In By firmary Health

New Technologies Produce Extraordinary Advances In Heart Disease Treatment

Joseph E. Parrillo, M.D. Chair, Heart & Vascular Hospital, Hackensack University Medical Center

right

The Role of Integrated Data in Achieving the Right Diagnosis and Treatment

By Homer Pien, Ph.D. Chief Scientific Officer, Diagnosis and Treatment, Philips

Tweet

Homer Pien, Ph.D. Chief Scientific Officer, Diagnosis and Treatment, Philips

Across the healthcare continuum today, there is growing pressure to transform the delivery system into one that achieves better outcomes at lower costs, and to do so in a more personalized and patient-friendly way. It’s a concept that’s easier said than done. Health systems are being forced to think and act differently to successfully address the challenges that surround this new way of care delivery. In an effort to achieve this goal, significant shifts are occurring along all stages of the patient journey.

"An accurate and definitive diagnosis plays a key role in the patient journey, as it sets the stage for treatment"

One change that is inevitable is the integration of radiology, pathology, genomics, and electronic health records (i.e., clinical history), which will allow for earlier and more personalized diagnosis and treatment. Between the growing role of AI in radiology, the digitalization of pathology and the expanded use of genomics, we’re seeing all theseareas evolving rapidly.

While radiology, pathology, and genomics are sometimes viewed as different disciplines today, there’s an exponential growth of data occurring within each discipline, which is leading to a greater need for integration. By integrating the abundant amount of data available in thesefields,invaluable insights on diseases that may otherwise be out of reach can be unlocked, resulting in the ability to significantly improve two key junctures in a patient’s care journey–diagnosis and treatment. It’s a concept that reverts back to one of the basic tenets of medicine–that the earlier you diagnose a disease; the earlier treatment can begin, driving lower costs and an improved chance at a better outcome. With greater, more personalized insights at these two points, clinicians are able to understand specific types of diseases, so the resulting intervention is more effective for the given patient.

An accurate and definitive diagnosis plays a key role in the patient journey, as it sets the stage for treatment. Integrated data from radiology, pathology, and genomics allows clinicians to have a very precise understanding of a patient’s specific disease type.

Consider the diagnosis of breast cancer for example. By combining the data from a diagnostic scan with the information from a pathology analysis, physicians are able to not only determine that the patient has breast cancer, but that it is a breast tumor with an ER-positive mutation and activation of the HH-pathway, and cells are proliferating rapidly and have progressed beyond the breast. The earlier physicians are able to make this conclusion, the earlier they are able to select and plan the right course of treatment–which may involve molecularly targeted drugs for these specific mutations, surgical intervention to precisely remove the bulk of the tumor, and radiation therapy. Because of how precisely we can understand the particulars of this patient’s disease (instead of just all breast cancer patients involving numerous types of mutations and expressions), we can look at past patients with this precise profile and understand what has worked and what hasn’t, and in turn select the best treatment for this patient. In doing so, patient outcome not only has the potential to be significantly improved, but the cost associated is decreased because the selected therapy is much more likely to be effective.

An important consideration in having a highly precise diagnosis so as to enable the selection of the optimal treatment strategy may be no treatment at all. As an example, we’re starting to gain a deeper understanding of prostate cancer, and given some of the potentially severe side effects of treatment, sometimes the best strategy in dealing with prostate cancers that are very unaggressive may be active surveillance. It has now been documented that many men who die of old age in fact had non-aggressive forms of prostate cancer, and this presence of the cancer did not affect the lifestyle of these patients. An active-surveillance strategy can strike the right balance between the benefits and risks of treatment, and precise diagnosis will allow us to make such informed decisions more intelligently, together with the patient.

To improve outcomes while reducing costs, physicians need to be able to diagnose the patient earlier and more definitively. Connecting the data across radiology, pathology, and genomics will be key in overcoming obstacles to diagnostic confidence and expediting the path to a “first time right” clinical decision-making process.

Read Also

You Can't Have One Without The Other: Value And Tech

You Can't Have One Without The Other: Value And Tech

Thomas J. Van Gilder, M.D., Chief Medical Officer, Transcend Insights
Transforming Cardio-Vascular Healthcare Systems

Transforming Cardio-Vascular Healthcare Systems

Vincent J Pompili MD. FACC, FSCAI, SVP, Novant Health
Diagnostic Devices Transforming The Cardiovascular Space

Diagnostic Devices Transforming The Cardiovascular Space

Mina Jacob, Interventional Cardiologist, In By firmary Health
New Technologies Produce Extraordinary Advances In Heart Disease Treatment

New Technologies Produce Extraordinary Advances In Heart Disease Treatment

Joseph E. Parrillo, M.D. Chair, Heart & Vascular Hospital, Hackensack University Medical Center

Weekly Brief

loading
Top 10 CardioVascular Device Companies - 2019
ON THE DECK

CardioVascular 2019

Top Vendors

CardioVascular 2018

Top Vendors

Previous Next

Featured Vendors

  • SentiAR: Enhancing Visibility intoInterventional Electrophysiological Procedures
    SentiAR: Enhancing Visibility intoInterventional Electrophysiological Procedures
  • Spaulding Medical: Cardiac Care to Avert False Alarms
    Spaulding Medical: Cardiac Care to Avert False Alarms
  • Keystone Heart, LTD.: Protecting the Brain during Cardiovascular Procedures
    Keystone Heart, LTD.: Protecting the Brain during Cardiovascular Procedures
  • PQ Bypass: Reimagining Long-Segment Peripheral Artery Treatment
    PQ Bypass: Reimagining Long-Segment Peripheral Artery Treatment
Copyright © 2019 Medical Tech Outlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy.
follow on linkedin follow on twitter
This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

cardiovascular.medicaltechoutlook.com/cxoinsight/the-role-of-integrated-data-in-achieving-the-right-diagnosis-and-treatment-nwid-105.html